Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 5.11
+0.13 (2.61%)
At close: Jul 3, 2026
SHA:688373 Market Cap
SHA:688373 has a market cap or net worth of 3.35 billion as of July 2, 2026. Its market cap has decreased by -20.21% in one year.
Market Cap
3.35B
Enterprise Value
3.30B
Revenue
150.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.11
Market Cap Chart
Since August 5, 2022, SHA:688373's market cap has decreased from 7.13B to 3.35B, a decrease of -52.96%. That is a compound annual growth rate of -17.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 3.35B | -15.32% |
| Dec 31, 2025 | 3.96B | 22.34% |
| Dec 31, 2024 | 3.24B | -24.35% |
| Dec 29, 2023 | 4.28B | -26.30% |
| Dec 30, 2022 | 5.81B | -18.57% |
| Aug 5, 2022 | 7.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Wohua Pharmaceutical | 3.52B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 3.51B |
| Nanjing Well Pharmaceutical Group | 3.51B |
| Zhuhai Rundu Pharmaceutical | 3.49B |
| Tibet AIM Pharm. | 3.46B |
| Zhejiang Cheng Yi Pharmaceutical | 3.43B |
| PKU HealthCare Corp.,Ltd. | 3.09B |
| Huaren Pharmaceutical | 3.07B |